MeSH term
Frequency | Condition_Probility | Female | 4 | 0.0 |
Fluorescent Antibody Technique, Direct | 2 | 1.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Humans | 16 | 0.0 |
Middle Aged | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 13 | 0.0 |
Animals | 9 | 0.0 |
Cattle | 2 | 0.0 |
Desmosomes/*metabolism | 3 | 21.0 |
Cell Line | 3 | 0.0 |
Cloning, Molecular | 6 | 0.0 |
Cytoskeletal Proteins/*genetics | 4 | 3.0 |
Membrane Glycoproteins/*genetics | 4 | 0.0 |
Immunoblotting | 3 | 0.0 |
Skin Diseases, Vesiculobullous/*immunology | 2 | 9.0 |
Base Sequence | 6 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Molecular Sequence Data | 7 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Blotting, Northern | 2 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Comparative Study | 3 | 0.0 |
Male | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 4 | 0.0 |
Cell Adhesion Molecules/genetics | 2 | 4.0 |
*Chromosomes, Human, Pair 18 | 3 | 2.0 |
*Linkage (Genetics) | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Cytoskeletal Proteins/metabolism | 2 | 0.0 |
Mice | 2 | 0.0 |
